About LIGATRAP TECHNOLOGIES, LLC
ChromaGenix develops novel affinity ligands and purification resins to help biopharma manufacturers purify complex biologics more efficiently with improved yields. Their technologies focus on complex modalities such as DNA, mRNA, viral vectors, exosomes, and lipid nanoparticles.
Development of novel affinity ligands and purification resinsPurification of complex biologics with improved yieldsDownstream purification solutions for emerging biopharma challengesAffinity chromatography for AAVs, IgM, and antibodiesCustom purification services
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to LIGATRAP TECHNOLOGIES, LLC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.